- Home
- IMCR vs GOGL Comparison
IMCR vs GOGL Comparison
Compare IMCR & GOGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- GOGL
- Stock Information
- Founded
- IMCR 2008
- GOGL N/A
- Country
- IMCR United Kingdom
- GOGL Bermuda
- Employees
- IMCR N/A
- GOGL N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- GOGL Marine Transportation
- Sector
- IMCR Health Care
- GOGL Consumer Discretionary
- Exchange
- IMCR Nasdaq
- GOGL Nasdaq
- Market Cap
- IMCR 1.7B
- GOGL 1.6B
- IPO Year
- IMCR 2021
- GOGL 1997
- Fundamental
- Price
- IMCR $35.17
- GOGL $8.67
- Analyst Decision
- IMCR Buy
- GOGL Hold
- Analyst Count
- IMCR 10
- GOGL 2
- Target Price
- IMCR $58.13
- GOGL $10.25
- AVG Volume (30 Days)
- IMCR 250.5K
- GOGL 3.4M
- Earning Date
- IMCR 08-07-2025
- GOGL 08-27-2025
- Dividend Yield
- IMCR N/A
- GOGL 12.12%
- EPS Growth
- IMCR N/A
- GOGL N/A
- EPS
- IMCR N/A
- GOGL 0.57
- Revenue
- IMCR $333,581,000.00
- GOGL $863,612,000.00
- Revenue This Year
- IMCR $26.82
- GOGL N/A
- Revenue Next Year
- IMCR $8.15
- GOGL $11.09
- P/E Ratio
- IMCR N/A
- GOGL $15.15
- Revenue Growth
- IMCR 25.75
- GOGL N/A
- 52 Week Low
- IMCR $23.15
- GOGL $6.27
- 52 Week High
- IMCR $40.88
- GOGL $13.44
- Technical
- Relative Strength Index (RSI)
- IMCR 53.52
- GOGL 67.07
- Support Level
- IMCR $32.20
- GOGL $8.07
- Resistance Level
- IMCR $37.63
- GOGL $8.40
- Average True Range (ATR)
- IMCR 1.21
- GOGL 0.22
- MACD
- IMCR 0.03
- GOGL 0.05
- Stochastic Oscillator
- IMCR 53.90
- GOGL 94.79
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About GOGL Golden Ocean Group Limited
Golden Ocean Group Ltd is a Bermuda-based dry bulk shipping company. Its business involves the transportation of dry bulk cargo including ores, coal, grains and fertilizers through its fleet of owned and chartered vessels, bareboat vessels, commercial management vessels and new buildings are chartered-out on fixed rate time charters and index-linked time charter contracts. The Company's single operating segment derives revenue from transporting dry bulk cargoes and chartering vessels to customers on time charter or voyage charter contracts.